Article

Analysis of the citric acid cycle intermediates using gas chromatography-mass spectrometry

Department of Nutrition, Mouse Metabolic Phenotyping Center, Case Western Reserve University, Cleveland, OH, USA.
Methods in molecular biology (Clifton, N.J.) (Impact Factor: 1.29). 01/2011; 708:147-57. DOI: 10.1007/978-1-61737-985-7_8
Source: PubMed

ABSTRACT Researchers view analysis of the citric acid cycle (CAC) intermediates as a metabolomic approach to identifying unexpected correlations between apparently related and unrelated pathways of metabolism. Relationships of the CAC intermediates, as measured by their concentrations and relative ratios, offer useful information to understanding interrelationships between the CAC and metabolic pathways under various physiological and pathological conditions. This chapter presents a relatively simple method that is sensitive for simultaneously measuring concentrations of CAC intermediates (relative and absolute) and other related intermediates of energy metabolism using gas chromatography-mass spectrometry.

Download full-text

Full-text

Available from: Rajan Kombu, Jul 24, 2015
1 Follower
 · 
279 Views
  • Source
    • "In recent years, several techniques have emerged that could measure CAC intermediates with greater precision, albeit still with limited coverage. In particular these include LC–MS/MS techniques developed by Luo et al. 2007 (Luo et al. 2007) and Koubaa et al. 2013 (Koubaa et al. 2013), GC/MS methodologies (Dunn and Winder 2011; Kombu et al. 2011), HPLC-fluorescence methodology (Kubota et al. 2005), capillary electrophoresis coupled to a mass spectrometer (CE/MS) (Soga et al. 2003; Wakayama et al. 2010), as well as 1 H NMR (Xu et al. 2011). 1 H NMR permits a greater coverage of the CAC intermediates as well as other metabolites (Xu et al. 2011) and does not require isotopically labeled internal standards. However, it is limited by the low micromolar sensitivity and potential spectral overlap. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The quantitative profiling of the organic acid intermediates of the citric acid cycle (CAC) presents a challenge due to the lack of commercially available internal standards for all of the organic acid intermediates. We developed an analytical method that enables the quantitation of all the organic acids in the CAC in a single stable isotope dilution GC/MS analysis with deuterium-labeled analogs used as internal standards. The unstable α-keto acids are rapidly reduced with sodium borodeuteride to the corresponding stable α-deutero-α-hydroxy acids and these, along with their unlabeled analogs and other CAC organic acid intermediates, are converted to their tert-butyldimethylsilyl derivatives. Selected ion monitoring is employed with electron ionization. We validated this method by treating an untransformed mouse mammary epithelial cell line with well-known mitochondrial toxins affecting the electron transport chain and ATP synthase, which resulted in profound perturbations of the concentration of CAC intermediates. Electronic supplementary material The online version of this article (doi:10.1007/s11306-013-0521-1) contains supplementary material, which is available to authorized users.
    Metabolomics 10/2013; 9(5):1019-1030. DOI:10.1007/s11306-013-0521-1 · 3.97 Impact Factor
  • Source
    • "The mass spectra of the TMS-derivatized compounds formed in the EI source led to fragment ions predicted from their chemical structure. The monitored ions were in accordance with research in which the analytes were determined using the same derivatizing reagent [16] [18]. The quantitation ions for all target compounds, including the internal standard, are shown in Table 2, which also includes the chromatographic retention times. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Metabolites involved in the tricarboxylic acid (TCA) cycle have previously been proposed as cardiovascular biomarkers. This cycle plays a key role in cell metabolism and the levels of the involved metabolites can also be affected by other physiological factors. The influence of three cardiovascular risk factors such as obesity, hypercholesterolemia, and smoking habit on serum levels of TCA-cycle metabolites has been studied in patients diagnosed with significant coronary lesion. For this purpose, a method based on GC-MS for determination of the target metabolites (viz. citric/isocitric, pyruvic, aconitic, oxaloacetic, malic, fumaric and succinic acids) in serum has been developed. The high accuracy and throughput analysis featuring the method have allowed application to a cohort of 223 patients, 172 of them with significant coronary lesion. Multifactor analysis of variance has revealed interactions between the occurrence or not of a coronary lesion and the risk factors considered in this study. These interactions were crucial to explain the levels of target TCA metabolites. Statistical evaluation by ROC curves allowed discrimination of the capability of significant metabolites with the occurrence of coronary lesions.
    Journal of pharmaceutical and biomedical analysis 02/2013; 74:178-85. DOI:10.1016/j.jpba.2012.10.029 · 2.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Brain glucose supplies most of the carbon required for acetyl-coenzyme A (acetyl-CoA) generation (an important step for myelin synthesis) and for neurotransmitter production via further metabolism of acetyl-CoA in the tricarboxylic acid (TCA) cycle. However, it is not known whether reduced brain glucose transporter type I (GLUT-1) activity, the hallmark of the GLUT-1 deficiency (G1D) syndrome, leads to acetyl-CoA, TCA or neurotransmitter depletion. This question is relevant because, in its most common form in man, G1D is associated with cerebral hypomyelination (manifested as microcephaly) and epilepsy, suggestive of acetyl-CoA depletion and neurotransmitter dysfunction, respectively. Yet, brain metabolism in G1D remains underexplored both theoretically and experimentally, partly because computational models of limited brain glucose transport are subordinate to metabolic assumptions and partly because current hemizygous G1D mouse models manifest a mild phenotype not easily amenable to investigation. In contrast, adult antisense G1D mice replicate the human phenotype of spontaneous epilepsy associated with robust thalamocortical electrical oscillations. Additionally, and in consonance with human metabolic imaging observations, thalamus and cerebral cortex display the lowest GLUT-1 expression and glucose uptake in the mutant mouse. This depletion of brain glucose is associated with diminished plasma fatty acids and elevated ketone body levels, and with decreased brain acetyl-CoA and fatty acid contents, consistent with brain ketone body consumption and with stimulation of brain beta-oxidation and/or diminished cerebral lipid synthesis. In contrast with other epilepsies, astrocyte glutamine synthetase expression, cerebral TCA cycle intermediates, amino acid and amine neurotransmitter contents are also intact in G1D. The data suggest that the TCA cycle is preserved in G1D because reduced glycolysis and acetyl-CoA formation can be balanced by enhanced ketone body utilization. These results are incompatible with global cerebral energy failure or with neurotransmitter depletion as responsible for epilepsy in G1D and point to an unknown mechanism by which glycolysis critically regulates cortical excitability.
    Neurobiology of Disease 04/2012; 48(1):92-101. DOI:10.1016/j.nbd.2012.04.011 · 5.20 Impact Factor
Show more